Santen Pharmaceutical Co Ltd 2024 Annual Report with Sustainability Disclosures
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 80
The report presents Santen's FY2023 record revenue of JPY 302.0 billion and highlights structural reforms that improved profitability. It emphasizes expansion into myopia and ptosis, including development of new treatment options. Sustainability coverage includes TCFD-based climate disclosures, SBTi-approved 2030 targets on a path to net zero by 2050, a biodiversity policy, waste reduction, and human-capital initiatives. It also details the Noto Plant earthquake response and restoration of production lines.
Services
From bulk PDFs to structured indicators and machine-readable documents.